Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · IEX Real-Time Price · USD
1.250
+0.030 (2.46%)
Jul 22, 2024, 10:08 AM EDT - Market open

Iterum Therapeutics Statistics

Total Valuation

ITRM has a market cap or net worth of $20.81 million. The enterprise value is $22.04 million.

Market Cap 20.81M
Enterprise Value 22.04M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, before market open.

Earnings Date Aug 9, 2024
Ex-Dividend Date n/a

Share Statistics

ITRM has 16.55 million shares outstanding. The number of shares has increased by 21.69% in one year.

Shares Outstanding 16.55M
Shares Change (YoY) +21.69%
Shares Change (QoQ) +17.07%
Owned by Insiders (%) 1.34%
Owned by Institutions (%) 5.65%
Float 16.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.07

Current Ratio 1.07
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -22.12

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -104.20%
Return on Capital (ROIC) -323.49%
Revenue Per Employee n/a
Profits Per Employee -$2.54M
Employee Count 14
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ITRM has paid $538,000 in taxes.

Income Tax 538,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +7.49% in the last 52 weeks. The beta is 2.25, so ITRM's price volatility has been higher than the market average.

Beta (5Y) 2.25
52-Week Price Change +7.49%
50-Day Moving Average 1.34
200-Day Moving Average 1.43
Relative Strength Index (RSI) 44.16
Average Volume (20 Days) 270,422

Short Selling Information

The latest short interest is 1.28 million, so 7.74% of the outstanding shares have been sold short.

Short Interest 1.28M
Short Previous Month 1.27M
Short % of Shares Out 7.74%
Short % of Float 7.89%
Short Ratio (days to cover) 8.85

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -45.10M
Pretax Income -35.05M
Net Income -35.58M
EBITDA -32.21M
EBIT -33.53M
Earnings Per Share (EPS) -$2.65
Full Income Statement

Balance Sheet

The company has $18.25 million in cash and $20.09 million in debt, giving a net cash position of -$1.84 million or -$0.11 per share.

Cash & Cash Equivalents 18.25M
Total Debt 20.09M
Net Cash -1.84M
Net Cash Per Share -$0.11
Equity (Book Value) -6.15M
Book Value Per Share -0.37
Working Capital 1.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.82 million and capital expenditures -$13,000, giving a free cash flow of -$42.84 million.

Operating Cash Flow -42.82M
Capital Expenditures -13,000
Free Cash Flow -42.84M
FCF Per Share -$2.78
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ITRM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.69%
Shareholder Yield -21.69%
Earnings Yield -176.18%
FCF Yield -212.09%

Analyst Forecast

The average price target for ITRM is $6.00, which is 380.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.00
Price Target Difference 380.00%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on August 18, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date Aug 18, 2022
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 1